skip to Main Content

AIM round-up: Arecor Therapeutics, Aura Energy, Quiz


Another solid day of gains saw the AIM Index add almost 10 points by the bell to reach 1269.83, with investors continuing to shake off that wide ranging list of economic uncertainties.

  • Arecor Therapeutics +47%
  • Aura Energy +36%
  • GCM Resources -22%
  • Igas Energy -16%
  • Quiz +27%

Arecor Therapeutics [LON:AREC] found itself at up 47% the top of the board today and back on our agenda for the second time this week. Shares soared on Monday before slipping back a little yesterday, but there’s no fresh news behind this latest leg-up. The stock remains in high demand, but a limited number of transactions appears to be pushing out the spread.

Aura Energy [LON:AURA] jumped 36% this morning off the news that trading was to resume on the ASX, now that the company has met with various qualifying requirements. Assay results are due shortly and these could see further cost savings in the project.

A notable mention for fashion house Quiz [LON:QUIZ] whose shares jumped 27% today. Shares are trading at their highest level in more than two years right now, but still sit a long way below the £2 seen shortly after their debut. Lop sided demand means the spread is around the 10% mark but numbers are due shortly and hopes are evidently running high.

GCM Resources [LON:GCM] was propping up the index today, with the minnow down by 22%. China has announced that it will stop developing coal fired power plants overseas and this has shaken the miner which has been partnering with the Chinese on such projects.

Igas Energy [LON:IGAS] fell again, dropping a further 16% by the bell with this morning’s interim results giving investors nothing more to cheer. The shares have had a rollercoaster ride over the last week, doubling in value before giving the vast majority of the gains straight back, despite a slew of good news. Limited free float may be skewing the performance, but does the recent good news really count for nothing?

Like this article? Sign up to our free newsletter.

This article does not constitute investment advice. Do your own research or consult a professional advisor.

The Armchair Trader's 'How to' Guides

In-depth Reports

Detailed reviews of selected companies and investment trusts.

Thanks to our Partners

Our partners are established, regulated businesses and we are grateful for their support.

FP Markets
Back To Top